ISSN (Online) : 2277-4572
Author(s): Ankita Tripathi *, Shubham Srivastava, Khushboo Bhardwaj, Sristi Raj, Nitin
Epilepsy is a severe neurological illness characterized by abnormal, recurring, and synchronized brain discharges. Long-term recurring seizure attacks can cause substantial brain function loss, as seen in people with temporal lobe epilepsy. Controlling seizure events is critical for epilepsy therapy and prognosis. The disease is more common in developing countries than in developed countries. The causes of epilepsy include chemical imbalances such as low blood sugar or sodium, head injuries, drug abuse or withdrawal, alcohol withdrawal, stroke tumor affecting the blood vessels (vascular system) in the brain, hardening of the arteries (atherosclerosis) in the brain, brain tumours, and brain infections such as meningitis or encephalitis. Given the prevalence of epilepsy and the challenges associated with currently available antiepileptic medicines, such as side effects, resistance, safety concerns, and high cost, screening models are utilized in epilepsy analysis. Screening models for seizures and epilepsy have been critical in expanding our understanding of the fundamental mechanisms underlying ictogenesis and epileptogenesis, as well as in the discovery and preclinical development of novel antiepileptic medicines (AEDs). Diverse screening models of epilepsy have been developed in recent years to imitate various seizure forms, with no clear advantages or disadvantages. In this study, we will cover the numerous screening models for epilepsy, which will aid in gaining a better understanding of the disease.
